Skip to main content
Livermore
Livermore
ZHEN

Citigroup Inc

SEC CIK
0000831001
Latest filing
Aug 3, 2026

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overviewAll 13F holders of KALVFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KALV by Citigroup Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−244,261−100.0%Sold outHolders
Q1 2026244,261$4.92M<0.1%+233,490+2,167.8%AddedHolders
Q4 202510,771$174.0K<0.1%−269,885−96.2%ReducedHolders
Q3 2025280,656$3.42M<0.1%−18,538−6.2%ReducedHolders
Q2 2025299,194$3.38M<0.1%+150,967+101.8%AddedHolders
Q1 2025148,227$1.71M<0.1%−179,069−54.7%ReducedHolders
Q4 2024327,296$2.77M<0.1%+21,792+7.1%AddedHolders
Q3 2024305,504$3.54M<0.1%+19,440+6.8%AddedHolders
Q2 2024286,064$3.37M<0.1%+3,181+1.1%AddedHolders
Q1 2024282,883$3.35M<0.1%+974+0.3%AddedHolders
Q4 2023281,909$3.45M<0.1%+4,991+1.8%AddedHolders
Q3 2023276,918$2.67M<0.1%−22,890−7.6%ReducedHolders
Q2 2023299,808$2.70M<0.1%+22,902+8.3%AddedHolders
Q1 2023276,906$2.18M<0.1%−165−0.1%ReducedHolders
Q4 2022277,071$1.87M<0.1%+276,402+41,315.7%AddedHolders
Q3 2022669$10.0K<0.1%−1,478−68.8%ReducedHolders
Q2 20222,147$21.0K<0.1%−6,290−74.6%ReducedHolders
Q1 20228,437$124.0K<0.1%−45,690−84.4%ReducedHolders
Q4 202154,127$716.0K<0.1%+25,139+86.7%AddedHolders
Q3 202128,988$506.0K<0.1%−68,829−70.4%ReducedHolders
Q2 202197,817$2.34M<0.1%+73,132+296.3%AddedHolders
Q1 202124,685$634.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.